Novonesis (Novozymes A/S)
26.2.2026 11:23:05 CET | Globenewswire | Press release
Trading by management and close relations of management
Trading by management and close relations of management
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B.
The Executive Leadership Team members eligible for the Novozymes A/S 2023-2025 incentive program has on February 25, 2026, received the allocated shares. An overview of the number and value of shares allotted is provided on the following pages.
Please read the full announcement in PDF.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
STS Digital Ltd.26.2.2026 14:35:48 CET | Press release
STS Digital Closes $30 Million Strategic Round from investors including CMT Digital and Payward to scale and strengthen its Crypto Options Trading Platform
Dantax A/S26.2.2026 14:30:17 CET | Pressemeddelelse
Dantax A/S - Ledende medarbejders transaktioner
Trident Resources Corp.26.2.2026 14:30:00 CET | Press release
Trident Resources Announces Purchase of Additional 4,711 Hectares at the Contact Lake Gold and Greywacke Gold Projects
Timeline Auctions Ltd26.2.2026 14:11:18 CET | Press release
Faces and Figures from Antiquity - Gods, Warriors and Emperors - Headline TimeLine’s 3 March Antiquities & Ancient Art Auction
ROCKWOOL A/S26.2.2026 14:06:39 CET | Press release
Completion of conversion of A shares to B shares in accordance with the articles of association and information on adjusted number of voting rights and share capital
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom